Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Ophthalmology · Thyroid Eye Disease

How Can I Cope With Thyroid Eye Disease Facial Changes?

At a Glance

Facial changes from thyroid eye disease can cause real anxiety, sadness, and social withdrawal. Tell your eye or thyroid specialist how you are coping; counseling, support groups, medical treatment, and later surgery may help, while sudden vision changes need urgent care.

Yes, it is common and understandable to feel distressed, anxious, or self-conscious about your appearance when you have thyroid eye disease (TED), also known as thyrotoxic exophthalmos or Graves’ orbitopathy. The urge to isolate yourself or hide from others is a recognized reaction to the facial changes caused by this condition. You are not being vain; distress over altered facial features is an important and documented part of the disease burden.


Urgent Safety Warning

  • Mental Health: If you are experiencing thoughts of self-harm, suicide, or feel unable to stay safe, contact your local emergency services or a crisis hotline immediately. Do not wait for a routine eye appointment.
  • Vision Safety: Worsening eye prominence or swelling is not just an appearance issue. If you experience new or worsening vision loss, reduced color vision (colors look washed out), a new blind spot, rapidly worsening pain, or the inability to close your eyelids, seek urgent ophthalmic or emergency care. These can be signs of sight-threatening complications.

The Emotional Toll of Thyroid Eye Disease

TED often causes visible changes to the face, such as proptosis (bulging of the eyes), eyelid retraction, and swelling. Because the eyes are central to how we communicate, these changes can affect your self-image and relationships.

Research confirms that the psychological impact of TED can be substantial. Studies show that people with TED have higher rates of diagnosed depression and anxiety compared to the general public [1]. While estimates vary depending on the population and how symptoms are measured, some reviews suggest that 18% to 33% of patients experience significant depressive symptoms, and up to 41% experience anxiety [2]. It is also important to note that thyroid hormone imbalances themselves can contribute to mood swings and anxiety, compounding the emotional impact.

These emotional challenges do not always vanish once the initial inflammation settles down. TED has an “active” inflammatory phase and a “chronic” or “inactive” phase (where inflammation has settled, though facial changes often remain). Psychological distress frequently persists even when the disease is inactive [3][4].

Social Avoidance and Quality of Life

When your appearance changes unexpectedly, you may experience a desire to withdraw socially. Visible symptoms like bulging eyes or misaligned eyes (strabismus) are linked to a lower quality of life regarding appearance and social role functioning [5]. Many patients report that their symptoms negatively affect their daily lives, causing them to worry constantly about their appearance or whether their symptoms will worsen [6].

To measure how TED affects your daily life, doctors may use a specialized tool called the GO-QOL (Graves’ Ophthalmopathy Quality of Life) questionnaire [7]. This validated disease-specific assessment is scored from 0 to 100, where higher scores mean a better quality of life. It features two sections: one for visual function and one for appearance-related quality of life [8][9].

The appearance section of the GO-QOL helps capture an important part of your lived experience, not just what the doctor sees on an exam [10]. Your doctor might also use general screening tools like the Hospital Anxiety and Depression Scale (HADS) to check for mood symptoms [11]. While these questionnaires do not diagnose clinical depression or guarantee a specific treatment change, tracking your scores helps your care team understand the emotional weight of your facial changes [12].

Integrating Support into Your Care Plan

Many patients want to discuss the quality-of-life impacts of their disease with their physicians, yet some wait for the doctor to bring it up [6]. Do not hesitate to proactively share how you are feeling with your endocrinologist or ophthalmologist.

Consider taking the following steps to support your mental health and physical recovery:

  • Ask about Quality-of-Life Tracking: Request that your doctor use the GO-QOL or a similar tool to track your well-being over time, which can help guide clinical conversations [12].
  • Discuss Mental Health Support: Counseling or working with a therapist who understands chronic illness may provide coping strategies for anxiety and social avoidance. Ask your doctor if a referral is appropriate for your symptoms.
  • Explore Support Groups: Connecting with reputable TED support organizations can validate your feelings and may help reduce isolation.
  • Discuss Medical and Surgical Options: Depending on whether your TED is active or inactive, the severity of your symptoms, and your vision risks, there may be treatments available. Targeted medications or rehabilitative surgeries (like orbital decompression or strabismus surgery) can sometimes improve appearance-related quality of life [13][14]. However, rehabilitative surgery is usually considered only after the disease has stabilized, comes with inherent risks, and is not a guaranteed cosmetic fix. Discuss the timing, eligibility, and realistic expectations with an ophthalmologist experienced in TED.

Common questions in this guide

Why do facial changes from thyroid eye disease feel so upsetting?
Bulging eyes, eyelid changes, swelling, or misaligned eyes can change how you see yourself and how you interact with others. Anxiety, sadness, worry, and wanting to avoid people are recognized effects of thyroid eye disease, not a sign that you are being vain.
How can I get support for anxiety or social withdrawal caused by TED?
Tell your ophthalmologist or endocrinologist how your appearance is affecting your daily life, even if they do not ask first. A counselor or therapist familiar with chronic illness, along with a reputable thyroid eye disease support group, may help you develop coping strategies and feel less isolated.
What is the GO-QOL questionnaire used for?
The GO-QOL is a questionnaire that helps your care team track how thyroid eye disease affects visual function and appearance-related quality of life. Scores range from 0 to 100, with higher scores indicating better quality of life; it supports discussion but does not diagnose depression or determine treatment by itself.
Can thyroid eye disease treatment improve how my face looks?
Depending on whether the disease is active or stable, its severity, and any vision risk, medicines or rehabilitative surgery may improve appearance-related quality of life. Surgery to create more space around the eye or straighten misaligned eyes is usually considered after the disease has stabilized, carries risks, and is not guaranteed to produce a specific cosmetic result.
When do facial or vision changes from TED require urgent help?
Seek urgent eye or emergency care for new or worsening vision loss, colors that look washed out, a new blind spot, rapidly worsening pain, or inability to close your eyelids. If you have thoughts of self-harm or suicide or cannot stay safe, contact emergency services or a crisis hotline immediately rather than waiting for a routine appointment.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on thyrotoxic exophthalmos.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can we use the GO-QOL or a similar questionnaire to formally track how my appearance and vision are impacting my daily life?
  2. 2.Do you have a mental health professional, such as a psychologist or psychiatrist, whom you regularly refer your TED patients to?
  3. 3.Are my current thyroid hormone levels or medications potentially contributing to my mood symptoms?
  4. 4.Based on my current disease activity and severity, what is the sequence and timing of potential treatments (like medication or surgery) for my appearance-related symptoms?
  5. 5.What steps should I take if I notice sudden changes in my vision or eye comfort before my next scheduled appointment?

References

References (14)
  1. 1

    Evaluation of Depression and Anxiety in a Diverse Population With Thyroid Eye Disease Using the Nationwide NIH All of Us Database.

    Lee TC, Radha-Saseendrakumar B, Delavar A, et al.

    Ophthalmic plastic and reconstructive surgery 2023; (39(3)):281-287 doi:10.1097/IOP.0000000000002318.

    PMID: 36727790
  2. 2

    Psychological aspects of Graves' ophthalmopathy.

    Al-Badri WKW, Jellema HM, Potvin ARGG, et al.

    Endocrine connections 2024; (13(9)).

    PMID: 39032509
  3. 3

    Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States.

    Cockerham KP, Padnick-Silver L, Stuertz N, et al.

    Ophthalmology and therapy 2021; (10(4)):975-987 doi:10.1007/s40123-021-00385-8.

    PMID: 34478126
  4. 4

    Inflammatory and Noninflammatory Thyroid Eye Disease: Comparison of Disease Signs, Symptoms, and Quality of Life in Patients in the United States.

    Wang Y, Padnick-Silver L, Francis-Sedlak M, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2022; (28(9)):842-846 doi:10.1016/j.eprac.2022.06.003.

    PMID: 35714862
  5. 5

    Quality of life and psychosocial well-being in thyroid eye disease in Japan: pre-teprotumumab national survey.

    Emoto S, Bushita Y, Nagase T, et al.

    Journal of the Endocrine Society 2026; (10(7)):bvag069 doi:10.1210/jendso/bvag069.

    PMID: 42245252
  6. 6

    Impacts of Thyroid Eye Disease (TED), Beyond the Signs and Symptoms: Results from the ElevaTED Patient Survey.

    Abrams JG, Gustafson C, Danese SR, et al.

    Ophthalmology and therapy 2026; (15(7)):2395-2412 doi:10.1007/s40123-026-01393-2.

    PMID: 42268513
  7. 7

    Evaluation of quality of life in patients with Graves´ ophthalmopathy, before and after orbital decompression.

    Iacobæus L, Sahlin S

    Orbit (Amsterdam, Netherlands) 2016; (35(3)):121-5 doi:10.1080/01676830.2016.1176049.

    PMID: 27159575
  8. 8

    Establishing the usefulness of the GO-QOL in a UK hospital-treated population with thyroid eye disease in the CIRTED trial.

    Dietrich A, Taylor P, White P, et al.

    Psychology, health & medicine 2018; (23(sup1)):1341-1355 doi:10.1080/13548506.2018.1503693.

    PMID: 30092670
  9. 9

    GO-QOL--disease-specific quality of life questionnaire in Graves' orbitopathy.

    Sawicka-Gutaj N, Bednarczuk T, Daroszewski J, et al.

    Endokrynologia Polska 2015; (66(4)):362-6 doi:10.5603/EP.2015.0046.

    PMID: 26323474
  10. 10

    Which factors are associated with quality of life in patients with Graves' orbitopathy presenting for orbital decompression surgery?

    Wickwar S, McBain HB, Ezra DG, et al.

    Eye (London, England) 2015; (29(7)):951-7 doi:10.1038/eye.2015.76.

    PMID: 25998940
  11. 11

    Quality of Life in Thyroid Eye Disease: A Systematic Review.

    Lee THB, Sundar G

    Ophthalmic plastic and reconstructive surgery 2020; (36(2)):118-126 doi:10.1097/IOP.0000000000001446.

    PMID: 31567783
  12. 12

    Measuring Health-Related Quality of Life in Thyroid Eye Disease.

    Sharma A, Stan MN, Rootman DB

    The Journal of clinical endocrinology and metabolism 2022; (107(Suppl_1)):S27-S35 doi:10.1210/clinem/dgac230.

    PMID: 36346683
  13. 13

    Teprotumumab Improves Quality of Life in Thyroid Eye Disease: Meta-analysis and Matching-adjusted Indirect Comparison.

    Kahaly GJ, Xi A, Barretto N, et al.

    Journal of the Endocrine Society 2025; (9(6)):bvaf063 doi:10.1210/jendso/bvaf063.

    PMID: 40303547
  14. 14

    The Effect of Ophthalmic Surgery for Graves' Orbitopathy on Quality of Life: A Systematic Review and Meta-Analysis.

    Woo T, Li C, Ganesananthan S, et al.

    Thyroid : official journal of the American Thyroid Association 2022; (32(2)):177-187 doi:10.1089/thy.2021.0411.

    PMID: 34877883

This page provides general information about coping with facial changes in thyroid eye disease and does not replace medical advice. Contact your ophthalmologist or emergency services for urgent vision or safety concerns.